| Trial ID: | L0897 |
| Source ID: | NCT02216552
|
| Associated Drug: |
Resveratrol
|
| Title: |
Safety and Efficacy of Resveratrol for the Treatment of Non-Alcoholic Fatty Liver Disease and Associated Insulin Resistance in Overweight and Obese Adolescents
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD;TYPE 2 DIABETES;METABOLIC SYNDROME;NAFLD;TYPE 2 DIABETES;METABOLIC SYNDROME;NAFLD;TYPE 2 DIABETES;METABOLIC SYNDROME;NAFLD;TYPE 2 DIABETES;METABOLIC SYNDROME
|
| Interventions: |
Dietary Supplement: Resveratrol;Dietary Supplement: Placebo;Dietary Supplement: Resveratrol;Dietary Supplement: Placebo;Dietary Supplement: Resveratrol;Dietary Supplement: Placebo;Dietary Supplement: Resveratrol;Dietary Supplement: Placebo
|
| Outcome Measures: |
Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Efficacy Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Efficacy Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Safety/ Adverse Event Outcome;Efficacy OutcomeEfficacy Outcome;Efficacy Outcome;Efficacy Outcome;Efficacy Outcome;Efficacy Outcome;Efficacy Outcome
|
| Sponsor/Collaborators: |
University of Manitoba
|
| Gender: |
All
|
| Age: |
13 Years18 Years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
10
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
12/08/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
Canada;Canada;Canada;Canada;Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT02216552
|
